E
Elysium Health
Revolutionary health products, based on advances in science and technology, to help people live healthier for longer
About Elysium Health
Elysium Health operates in the life sciences sector, focusing on developing scientifically-backed health products aimed at improving cellular aging, DNA health, and brain function. The company serves health-conscious consumers who are interested in proactive health management and longevity. Elysium Health's business model revolves around direct-to-consumer sales of its flagship products, including Basis, Matter, and Index. Basis is a supplement clinically proven to increase NAD levels, which are essential for cellular health. Matter is designed to slow age-related brain atrophy with a specific B vitamin complex. Index is an at-home test that uses epigenetics technology to determine biological age. The company generates revenue through online sales and subscription models, ensuring a steady stream of income. Elysium Health differentiates itself through its commitment to scientific research and partnerships with leading academic institutions.
Source: Dealroom company dataNews
Open roles
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES COther financing | Sep 2021 | $0 | — | The Venture Collective | — |
| SERIES COther financing | Jan 2021 | $0 | — | Undisclosed | — |
Growth signals
Latest recorded traffic for Elysium Health is 81K monthly website visits, down 5.8% over the last three months. Elysium Health's team declined 2.5% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Elysium Health in the New York City ecosystem
The Elysium Health office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed1 investor entered at this stage
TYLT Ventures
Series A6 investors entered at this stage
OS Fund
General Catalyst
Sound Ventures
Morningside
Robert Nelsen
Breyer Capital
Series B and later6 investors entered at this stage
Standard Treasury
Silicon Valley Bank
GISEV Family Office
Western Technology Investment
5Y Capital
The Venture Collective
Other known investors1 additional known investor
Massachusetts Institute of Technology
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Elysium Health on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Elysium Health’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.










